Tract Bio
Business Services · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
29 S Main St, Boston, Massachusetts, 061...Website
www.tractbio.comRevenue
<$5 MillionIndustry
About Tract Bio
Tract Bio Org Chart
Chief Financial Officer & Chief Operating Off...
Is Tract Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Tract Bio
Click to see if Tract Bio had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Tract Bio has new funding data
Product Launch: Get notified when Tract Bio launches new products
Earning: See what the market has to say on Tract Bio recently announced quarterly report
Check if Tract Bio has recently received funding, and reach out quickly before it becomes old news!
Check out if Tract Bio is spiking on competitors!
Tract Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Tract Bio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Tract Bio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Tract Bio.
Tract Bio Tech Stack
A closer look at the technologies used by Tract Bio
Most Recent Scoops
Tract Bio News & Media
Tract Bio Appoints Chris Galloway, M.D., as Chief Medical and Development Officer and Expands Board of Directors
-- Chris Galloway, M.D., brings over two decades of medical practice, clinical development and leadership experience across therapeutic areas, including oncology and immunology, and will oversee a drug development pipeline of novel therapies leveraging Tract Bio's proprietary stemECHO™...Tract Bio Announces Publication in Gastroenterology Revealing Potential Therapeutic Targets in the Evolution of Esophageal Adenocarcinoma Identified Using stemECHO™ Cloning Platform
Proprietary discovery platform, stemECHO, clones and characterizes the role of epithelial stem cells in the pathogenesis of inflammation and cancer, identifying druggable targets for the treatment and prevention of disease BOSTON, March 17, 2025 /PRNewswire/ -- Tract Bio, a biotechnology...
Top Business Services Companies
Frequently Asked Questions Regarding Tract Bio
Tract Bio is a biotechnology company specializing in a proprietary stem cell delivery platform known as stemECHO, which enables the identification of druggable targets for therapies aimed at cancer and inflammatory diseases. Their innovative technology allows for the cloning of epithelial stem cells while preserving genetic integrity, facilitating... Read More